Bromfenac sodium sesquihydrate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula 2C15H11BrNO3.2Na.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8ECV571Y37, chemically known as benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-, monosodium salt, sesquihydrate but more generally known as bromfenac sodium, which bears US NIH Compound Identifier 60725. European Medicines Agency schedules Bromfenac sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00874MIG. Most nations, for tariff and trade purposes, schedule bromfenac sodium sesquihydrate under HS 29225000. SMILES: C1CC(C(C(C1)C(=O)C2CCC(CC2)BR)N)CC(=O)[O-].C1CC(C(C(C1)C(=O)C2CCC(CC2)BR)N)CC(=O)[O-].O.O.O.[NA+].[NA+].